Human Oncology & Pathogenesis Program

The Ingo Mellinghoff Lab

Research

Pictured: Ingo Mellinghoff
Ingo K. Mellinghoff, MD, FACP

Our laboratory focuses on the study of molecular pathways that regulate brain tumor growth. Our long-term goal is to develop therapeutic paradigms that target specific properties of primary brain tumors, including genetic alterations in cancer signaling pathways, unique aspects of brain tumor metabolism, or interactions of brain tumor cells with their brain microenvironment.  Our studies in experimental brain tumor models are closely linked to the evaluation of novel agents in early-phase clinical trials.

The Ingo Mellinghoff Lab

Publications

View All Publications

People

Pictured: Ingo Mellinghoff

Ingo K. Mellinghoff, MD, FACP

  • Physician-scientist Ingo Mellinghoff studies signal transduction alterations in primary brain tumors.
  • MD, Technical University Munich (Germany)
646-888-2766
Office Phone
View physician profile
Physician profile

Members

Carl Campos
Carl Campos

Lab Manager

Christian Grommes, MD
Christian Grommes

Associate Attending

Owen Clark
Owen Clark

Senior Research Scientist

Maya Graham
Maya Graham

Instructor

Charli Hertz
Charli Hertz

Research Technician

Alex Lee
Alex Lee

Research Technician

Smrutiben Mehta
Smrutiben Mehta

Research Assistant

Alexandra  Miller
Alexandra Miller

Assistant Attending

Veronica Nagle
Veronica Nagle

Graduate Student

Daniel Navarrete
Daniel Navarrete

Senior Research Assistant

Maryam Pourmaleki
Maryam Pourmaleki

Graduate Student

Colin Tang
Colin Tang

Graduate Student

Sarah Tang
Sarah Tang
Lab Affiliations

Achievements

  • Member, Association of American Physicians (2020)
  • Member, American Society of Clinical Investigation (2013)
  • Advanced Clinical Research Award, American Society of Clinical Oncology (2009)
  • Clinical Scientist Development Award, Doris Duke Charitable Foundation (2008)
  • Translational Science Award, Sidney Kimmel Foundation (2008)
Read more
  • Distinguished Scientist, Sontag Foundation (2007)
  • Scholar, Forbeck Research Foundation (2005)
  • Young Investigator Award, American Society of Clinical Oncology (2003)

Open Positions

Career Opportunities

Apply now

Get in Touch

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Ingo K. Mellinghoff discloses the following relationships and financial interests:

  • Agios Pharmaceuticals
    Provision of Services
  • American Society of Clinical Oncology (ASCO)
    Provision of Services
  • AstraZeneca
    Provision of Services (uncompensated)
  • Cardinal Health
    Provision of Services
  • DC Europa Limited
    Provision of Services (uncompensated)
  • Doris Duke Charitable Foundation
    Provision of Services
  • European Association of Neuro-Oncology (EANO)
    Provision of Services (uncompensated)
  • Hartford Healthcare
    Provision of Services
  • MD Anderson
    Provision of Services
  • Novartis
    Provision of Services
  • Roche
    Provision of Services
  • Voyager Therapeutics Inc.
    Provision of Services

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.


View all disclosures